Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells

Journal of Pathology

Volumn 200, Issue 2, 2003, Pages 249-254

  Zhang, Chun Lei ^a,b   Kamarashev, Jivko ^a   Qin, Jian Zhong ^a,c   Burg, Günter ^a   Dummer, Reinhard ^a   Döbbeling, Udo ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF TEXAS   (United States)

^c University Medical Center   (United States)

Author keywords

Apoptosis; Cancer; Cutaneous cell lymphoma; Gene expression; Tumourigenesis

Indexed keywords

ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CYTOTOXIC AGENT; FLUOROURACIL; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN MCL 1; REGULATOR PROTEIN; SULINDAC;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INTRACELLULAR TRANSPORT; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SKIN BIOPSY;

AGED; ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; CARRIER PROTEINS; DRUG RESISTANCE; FEMALE; GENE EXPRESSION; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SKIN NEOPLASMS; SULINDAC; TUMOR CELLS, CULTURED;

EID: 0037531758     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1341     Document Type: Article

References (27)

1. Burg G, Kempf W, Häffner AC, et al. Cutaneous lymphomas. Curr Probl Dermatol 1997; 9: 139-204.
2. Girardi M, Edelson RL. Cutaneous T-cell lymphoma: pathogenesis and treatment. Oncology 2000; 14: 1061-1070.
3. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80: 879-886.
4. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
5. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a heteromeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285-291.
6. Osborne BA. Apoptosis and the maintenance of homeostasis in the immune system. Curr Opin Immunol 1996; 8: 245-254.
7. Kanavaros P, Ioannidou D, Tzardi M, et al. Mycosis fungoides: expression of c-myc, p62, p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol Res Pract 1994; 190: 767-774.
8. Dummer R, Michie SA, Kell D, et al. Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates. J Cutan Pathol 1995; 22: 11-17.
9. Garatti SA, Roscetti E, Trecca D, Fracchiolla NS, Neri A, Berti E. Bcl-1, bcl-2, p53, c-mye, and lyt-10 analysis in cutaneous lymphomas. Recent Results Cancer Res 1995; 139: 249-261.
10. Qin JZ, Zhang CL, Kamarashev J, Dummer R, Burg G, Döbbeling U. IL-7 and IL-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T cell lymphoma (CTCL) cells. Blood 2001; 98: 2778-2783.
11. Qin JZ, Dummer R, Burg G, Döbbeling U. Constitutive and interleukin-7/interleukin-15 stimulated DNA binding of Myc, Jun, and novel Myc-like proteins in cutaneous T-cell lymphoma cells. Blood 1999; 93: 260-267.
12. Döbbeling U, Dummer R, Laine E, Potoczna N, Qin JZ, Burg G. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood 1998; 92: 252-258.
13. Boise LH, Gonzalez-Garcia M, Postema CE, et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597-608.
14. Reynolds JE, Yang T, Qian L, et al. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 1994; 54: 6348-6352.
15. Rigal-Huguet F, Gopas J, Prinsloo I, et al. Frequent expression of the cell death-inducing gene Bax in Reed-Sternberg cells of Hodgkin's disease. Blood 1996; 87: 2470-2475.
16. Miyamoto Y, Hosotani R, Wada M, et al. Immunohistochemical analysis of Bcl-2, Bax, Bcl-x, and Mcl-1 expression in pancreatic cancers. Oncology 1999; 56: 73-82.
17. Krajewska M, Krajewski S, Epstein JI, et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 1996; 148: 1567-1576.
18. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14-3-3 not bcl-xL. Cell 1996; 87: 619-628.
19. Zhang L, Yu J, Park HP, Kinzler KW, Vogelstein B. Role of Bax in the apoptotic response to anticancer agents. Science 2000; 829: 989-992.
20. Kaltoft K, Bisballe S, Rasmussen HF, Thesstrup-Pedersen K, Thomsen K, Sterry W. A continuous T-cell line from a patient with Sézary syndrome. Arch Dermatol Res 1987; 279: 293-298.
21. Kaltoft K, Holm-Hansen B, Thesstrup-Pedersen K. Cytogenetic findings in cell lines from cutaneous T cell lymphoma. Dermatol Clinics 1994; 12: 295-304.
22. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J Biol Chem 1997; 272: 17 255-17 257.
23. Irmler M, Thome M, Hahne M, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190-195.
24. Kitada S, Andersen J, Akar S, et al. Expression of apoptosis regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 1996; 91: 3379-3389.
25. Rappl G, Kapsokefalou A, Heuser C, et al. Dermal fibroblasts sustain proliferation of activated T cells via membrane-bound interleukin-15 upon long-term stimulation with tumor necrosis factor alpha. J Invest Dermatol 2001; 116: 102-109.
26. Rappl G, Abken H, Hasselmann DO, Tilgen W, Ugurel S, Reinhold U. The CD7- subset of CD4+ memory T cells is prone to accelerated apoptosis that is prevented by interleukin-15 (IL-15). Cell Death Diff 2001; 8: 395-402.
27. Dalloul A, Laroche L, Bagot M, et al. Interleukin-7 is a growth factor for Sézary lymphoma cells. J Clin Invest 1992; 90: 1054-1060.